하스 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 김용수, was filed 01 Sept 2025.
하스: what insiders have been doing
Every trade that managers of 하스 disclose to DART (FSS) is tracked on this page. The company sits in the Health Care sector. The past year has been quiet: not a single insider filing for 하스. The previous disclosure was published on 1 September 2025.
Looking back to 2024, when coverage begins, insiders filed 9 purchases and 1 sale.
In the same sector, recent insider purchases at Cooper Companies, Inc. and Cytosorbents Corp also feature in our signals. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.
Who traded when
BuySaleTransparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 76,950 sharesKRXDART:20250901000526Canonical exit: 25 Nov 2025 (T+90)
- 38,880 sharesShareKRXDART:20250807000109Canonical exit: 5 Nov 2025 (T+90)
- Other0DART
- 47,520 sharesKRXDART:20250806000157
- 5,400 sharesShareKRXDART:20250806000173Canonical exit: 4 Nov 2025 (T+90)
- 287,993 sharesKRXDART:20240709000126Canonical exit: 1 Oct 2024 (T+90)
- 4,941,702 sharesKRXDART:20240709000365Canonical exit: 1 Oct 2024 (T+90)
- ShareKRXDART:20240708000151Canonical exit: 1 Oct 2024 (T+90)
- ShareKRXDART:20240708000177Canonical exit: 1 Oct 2024 (T+90)
- ShareKRXDART:20240708000193Canonical exit: 1 Oct 2024 (T+90)
- ShareKRXDART:20240705000391Canonical exit: 1 Oct 2024 (T+90)
11 of 11 declarations
About 하스
하스 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in the development and distribution of pharmaceutical products.
